Cargando…
Phase angle as a marker of outcome in hospitalized pediatric patients. A systematic review of the evidence (GRADE) with meta-analysis
Phase angle (PhA) is a valuable tool for evaluating the nutritional and inflammatory status, which can accompany acute and severe disorders. PhA is a cellular health biomarker, whose value is particularly substantial due to the negative consequences of these situations in the pediatric population. R...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404571/ https://www.ncbi.nlm.nih.gov/pubmed/37486555 http://dx.doi.org/10.1007/s11154-023-09817-1 |
_version_ | 1785085328245129216 |
---|---|
author | Fernández-Jiménez, Rocío Martín-Masot, Rafael Cornejo-Pareja, Isabel Vegas-Aguilar, Isabel M. Herrador-López, Marta Tinahones, Francisco J. Navas-López, Víctor Manuel Bellido-Guerrero, Diego García-Almeida, José Manuel |
author_facet | Fernández-Jiménez, Rocío Martín-Masot, Rafael Cornejo-Pareja, Isabel Vegas-Aguilar, Isabel M. Herrador-López, Marta Tinahones, Francisco J. Navas-López, Víctor Manuel Bellido-Guerrero, Diego García-Almeida, José Manuel |
author_sort | Fernández-Jiménez, Rocío |
collection | PubMed |
description | Phase angle (PhA) is a valuable tool for evaluating the nutritional and inflammatory status, which can accompany acute and severe disorders. PhA is a cellular health biomarker, whose value is particularly substantial due to the negative consequences of these situations in the pediatric population. Relevant literature was collected with the aim of comprehensively analysing the evidence on the association between an altered PhA can serve as a predictive-marker for mortality and poor-outcomes in at-risk-pediatric patients. Understanding this relationship could have significant implications for identifying high-risk individuals and implementing timely interventions. A systematic review with meta-analysis was conducted in the primary electronic databases from inception until January 2023. Overall, four studies with a total of 740 patients were eligible for our analysis. Evidence demonstrates that PhA is associated with nutritional status, reflecting undernutrition and changes in body composition related to illness. This review suggests that PhA can indeed be used as an indicator of nutritional status and a tool for predicting prognosis, including mortality and poor-outcomes, in hospitalized pediatric patients. A low PhA was associated with a significant mortality risk [RR:1.51;95%CI (1.22–1.88),p = 0.0002;I2 = 0%,(p = 0.99)] and an increased complications risk [OR:8.17;95%CI (2.44–27.4),p = 0.0007;I2 = 44%,(p = 0.18)]. These findings highlight the importance of taking a comprehensive approach to clinical nutrition, integrating multiple evaluation aspects to establish an accurate diagnosis and personalized therapeutic plans. While PhA emerges as a valuable tool for assessing the risk of malnutrition and as a prognostic-indicator for poor-outcomes in pediatric patients. Further future studies are needed to focus on investigating this relationship in larger and diverse population to strengthen the evidence base. GRAPHICAL ABSTRACT: [Image: see text] |
format | Online Article Text |
id | pubmed-10404571 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-104045712023-08-08 Phase angle as a marker of outcome in hospitalized pediatric patients. A systematic review of the evidence (GRADE) with meta-analysis Fernández-Jiménez, Rocío Martín-Masot, Rafael Cornejo-Pareja, Isabel Vegas-Aguilar, Isabel M. Herrador-López, Marta Tinahones, Francisco J. Navas-López, Víctor Manuel Bellido-Guerrero, Diego García-Almeida, José Manuel Rev Endocr Metab Disord Article Phase angle (PhA) is a valuable tool for evaluating the nutritional and inflammatory status, which can accompany acute and severe disorders. PhA is a cellular health biomarker, whose value is particularly substantial due to the negative consequences of these situations in the pediatric population. Relevant literature was collected with the aim of comprehensively analysing the evidence on the association between an altered PhA can serve as a predictive-marker for mortality and poor-outcomes in at-risk-pediatric patients. Understanding this relationship could have significant implications for identifying high-risk individuals and implementing timely interventions. A systematic review with meta-analysis was conducted in the primary electronic databases from inception until January 2023. Overall, four studies with a total of 740 patients were eligible for our analysis. Evidence demonstrates that PhA is associated with nutritional status, reflecting undernutrition and changes in body composition related to illness. This review suggests that PhA can indeed be used as an indicator of nutritional status and a tool for predicting prognosis, including mortality and poor-outcomes, in hospitalized pediatric patients. A low PhA was associated with a significant mortality risk [RR:1.51;95%CI (1.22–1.88),p = 0.0002;I2 = 0%,(p = 0.99)] and an increased complications risk [OR:8.17;95%CI (2.44–27.4),p = 0.0007;I2 = 44%,(p = 0.18)]. These findings highlight the importance of taking a comprehensive approach to clinical nutrition, integrating multiple evaluation aspects to establish an accurate diagnosis and personalized therapeutic plans. While PhA emerges as a valuable tool for assessing the risk of malnutrition and as a prognostic-indicator for poor-outcomes in pediatric patients. Further future studies are needed to focus on investigating this relationship in larger and diverse population to strengthen the evidence base. GRAPHICAL ABSTRACT: [Image: see text] Springer US 2023-07-24 2023 /pmc/articles/PMC10404571/ /pubmed/37486555 http://dx.doi.org/10.1007/s11154-023-09817-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Fernández-Jiménez, Rocío Martín-Masot, Rafael Cornejo-Pareja, Isabel Vegas-Aguilar, Isabel M. Herrador-López, Marta Tinahones, Francisco J. Navas-López, Víctor Manuel Bellido-Guerrero, Diego García-Almeida, José Manuel Phase angle as a marker of outcome in hospitalized pediatric patients. A systematic review of the evidence (GRADE) with meta-analysis |
title | Phase angle as a marker of outcome in hospitalized pediatric patients. A systematic review of the evidence (GRADE) with meta-analysis |
title_full | Phase angle as a marker of outcome in hospitalized pediatric patients. A systematic review of the evidence (GRADE) with meta-analysis |
title_fullStr | Phase angle as a marker of outcome in hospitalized pediatric patients. A systematic review of the evidence (GRADE) with meta-analysis |
title_full_unstemmed | Phase angle as a marker of outcome in hospitalized pediatric patients. A systematic review of the evidence (GRADE) with meta-analysis |
title_short | Phase angle as a marker of outcome in hospitalized pediatric patients. A systematic review of the evidence (GRADE) with meta-analysis |
title_sort | phase angle as a marker of outcome in hospitalized pediatric patients. a systematic review of the evidence (grade) with meta-analysis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404571/ https://www.ncbi.nlm.nih.gov/pubmed/37486555 http://dx.doi.org/10.1007/s11154-023-09817-1 |
work_keys_str_mv | AT fernandezjimenezrocio phaseangleasamarkerofoutcomeinhospitalizedpediatricpatientsasystematicreviewoftheevidencegradewithmetaanalysis AT martinmasotrafael phaseangleasamarkerofoutcomeinhospitalizedpediatricpatientsasystematicreviewoftheevidencegradewithmetaanalysis AT cornejoparejaisabel phaseangleasamarkerofoutcomeinhospitalizedpediatricpatientsasystematicreviewoftheevidencegradewithmetaanalysis AT vegasaguilarisabelm phaseangleasamarkerofoutcomeinhospitalizedpediatricpatientsasystematicreviewoftheevidencegradewithmetaanalysis AT herradorlopezmarta phaseangleasamarkerofoutcomeinhospitalizedpediatricpatientsasystematicreviewoftheevidencegradewithmetaanalysis AT tinahonesfranciscoj phaseangleasamarkerofoutcomeinhospitalizedpediatricpatientsasystematicreviewoftheevidencegradewithmetaanalysis AT navaslopezvictormanuel phaseangleasamarkerofoutcomeinhospitalizedpediatricpatientsasystematicreviewoftheevidencegradewithmetaanalysis AT bellidoguerrerodiego phaseangleasamarkerofoutcomeinhospitalizedpediatricpatientsasystematicreviewoftheevidencegradewithmetaanalysis AT garciaalmeidajosemanuel phaseangleasamarkerofoutcomeinhospitalizedpediatricpatientsasystematicreviewoftheevidencegradewithmetaanalysis |